December 1, 2024
Headlines

Biotech

Biophyle Unveils Groundbreaking Accelerator Program for Clinical-Stage Biotech Innovations and Local Research Training

Editor06 mins

In a major boost to healthcare innovation, SymBiosis and HealthTech Arkansas have announced the launch of the biophyle Trial Accelerator, a pioneering initiative aimed at bridging the gap between cutting-edge clinical-stage biotherapeutics and Arkansas’ healthcare ecosystem. This strategic program is designed to catalyze the commercialization of novel treatments by connecting biotherapeutic innovations with clinical trial…

Read More

Pinetree Therapeutics Raises $17M to Propel Breakthrough Cancer Therapies with Innovative Protein Degradation Platform

Editor03 mins

Pinetree Therapeutics, Inc., a trailblazer in targeted protein degradation (TPD) technology, has successfully closed a Series A funding round, raising $17 million to advance its AbReptor™ platform. This investment round was co-led by STIC Investments and DSC Investment, with new participation from Atinum Investment, Quantum FA, and S&S Investment, alongside existing backers DSC Investment, Schmidt,…

Read More

Armata Pharmaceuticals Secures $5.25 Million DoD Grant to Advance Groundbreaking Phage Therapy for Staphylococcus aureus Bacteremia

Editor05 mins

Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a leader in the development of cutting-edge bacteriophage therapies, has been awarded an additional $5.25 million in non-dilutive funding by the U.S. Department of Defense (DoD). This significant grant, facilitated through the Medical Technology Enterprise Consortium (MTEC) and managed by the Naval Medical Research Command (NMRC) and the Joint…

Read More

Spear Bio Secures $45 Million in Oversubscribed Series A Round to Revolutionize Protein Research and Diagnostics

Editor04 mins

Spear Bio Inc., an innovative biotechnology company specializing in ultra-sensitive protein detection, has successfully closed an oversubscribed $45 million Series A financing round. The investment was co-led by Foresite Capital and Bio-Techne Corporation, with additional support from Maverick Ventures, Yonjin Capital, and CDH Investments. Vikram Bajaj, Managing Director at Foresite Capital, will join Spear Bio’s…

Read More

Synthetica Pioneering Secures Series A Funding to Accelerate Oncolytic Bacterial Therapy for Solid Tumors

Editor05 mins

Shenzhen Synthetica Pioneering Co., Ltd. has successfully concluded a Series A funding round, raising significant capital to propel its innovative oncolytic bacterial therapy into clinical trials. This funding milestone, spearheaded by prominent investors including Boehringer Ingelheim Venture Fund and Temasek, along with contributions from Lenovo Capital, Fosun Health Capital, and ATLATL Summer Fund, underscores the…

Read More

Truvian Health Secures $74M to Democratize Access to Blood Testing Anywhere

Editor04 mins

Truvian Health, a pioneering force in healthcare innovation, has announced a significant milestone with the successful closure of a $74 million funding round aimed at revolutionizing the accessibility of blood testing. This funding, led by Wittington Ventures and Great Point Ventures, marks a pivotal moment for Truvian as it prepares to advance its groundbreaking blood…

Read More

Cardurion Pharmaceuticals Secures $260 Million Series B to Advance Cardiovascular Drug Pipeline

Editor04 mins

Cardurion Pharmaceuticals, a pioneering biotechnology firm specializing in innovative therapies for cardiovascular diseases, has announced the successful completion of a $260 million Series B financing round. Led by Ascenta Capital and supported by a consortium of esteemed investors including NEA, GV, and Fidelity Management & Research Company, this substantial funding underscores Cardurion’s commitment to advancing…

Read More

AusperBio Secures $37 Million Series A Funding to Accelerate Development of Hepatitis B Therapy

Editor04 mins

AusperBio Therapeutics, Inc., a pioneering biotechnology firm focused on targeted oligonucleotide therapies for chronic hepatitis B (CHB), has announced the successful completion of a $37 million Series A financing round. This funding, spearheaded by existing investor InnoPinnacle Fund and bolstered by new investors including Yuanbio Venture Capital, Qiming Venture Partners, Hankang Capital, and Genesis Capital,…

Read More

Element Biosciences Secures $277 Million to Propel Innovation in DNA Sequencing and Multi-Omics

Editor05 mins

Element Biosciences, a trailblazer in advancing scientific discovery through groundbreaking technologies, has announced a significant milestone in its journey of innovation. The company has successfully raised over $277 million in Series D funding, underscoring its pivotal role in revolutionizing DNA sequencing and multi-omics technologies. This latest round, led by Wellington Management and supported by a…

Read More

HepaRegeniX Secures €15 Million Series C Funding to Propel Clinical Development of HRX-215 for Liver Regeneration

Editor04 mins

HepaRegeniX GmbH, a pioneering clinical-stage biotechnology firm specializing in regenerative therapies for liver diseases, has announced the successful closure of a Series C funding round totaling €15 million. Led by Vesalius Biocapital IV and supported by existing investors including Novo Holdings, Boehringer Ingelheim Venture Fund (BIVF), and High-Tech Gründerfonds (HTGF), this investment will accelerate the…

Read More